Paul Buchan is a partner at Milbank in the London office, where he is a member of the firm's Global Corporate Group. His practice is centered on private equity transactions, representing private equity houses, financial sponsors, and other stakeholders in corporate transactions such as acquisitions, disposals, and reorganizations across various sectors and geographies. Notable transactions include advising Vitruvian Partners on the sale of Phlexglobal, Dentex Healthcare Group on its sale to Portman Healthcare, and Scottish Rugby on CVC's investment in the Pro14 League and Six Nations Tournament. Before joining Milbank, Paul was a partner at a boutique law firm specializing in corporate law and private equity matters.
